{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:57:22Z","timestamp":1771667842741,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.medcli.2017.07.026","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T16:50:10Z","timestamp":1507827010000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Polimorfismos de los genes APOA1 y APOB y concentraciones de sus apolipoprote\u00ednas como biomarcadores de riesgo en el s\u00edndrome coronario agudo: relaci\u00f3n con la efectividad del tratamiento hipolipemiante"],"prefix":"10.1016","volume":"151","author":[{"given":"Fidel","family":"Casillas-Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeminia","family":"Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Francisco","family":"Mu\u00f1oz-Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana Emilia","family":"Mart\u00ednez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela Lizet","family":"Reynoso-Villalpando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor Enrique","family":"Flores-Salinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara Ana\u00eds","family":"Llamas-Covarrubias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge Ram\u00f3n","family":"Padilla-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2017.07.026_bib0175","unstructured":"World Health Organization. Cardiovascular diseases (CVDs) [Internet]. WHO; 2017 [consultado 17 Jul 2016]. Disponible en: http:\/\/www.who.int\/mediacentre\/factsheets\/fs317\/en\/"},{"key":"10.1016\/j.medcli.2017.07.026_bib0180","first-page":"207","article-title":"Third national registry of acute coronary syndromes (RENASICA III)","volume":"85","author":"Jerjes-Sanchez","year":"2015","journal-title":"Arch Cardiol Mex"},{"key":"10.1016\/j.medcli.2017.07.026_bib0185","unstructured":"Principales causas de mortalidad por residencia habitual, grupos de edad y sexo del fallecido [Internet] [consultado 13 Sep 2017]. Disponible en: http:\/\/www.inegi.org.mx\/est\/contenidos\/proyectos\/registros\/vitales\/mortalidad\/tabulados\/pc.asp?t=14&c=11817"},{"key":"10.1016\/j.medcli.2017.07.026_bib0190","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1161\/CIRCRESAHA.114.302805","article-title":"Lipoproteins as biomarkers and therapeutic targets in the setting of acute coronary syndrome","volume":"114","author":"Rosenson","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.medcli.2017.07.026_bib0195","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1365-2796.2002.01029.x","article-title":"Heritability of death from coronary heart disease: A 36-year follow-up of 20 966 Swedish twins","volume":"252","author":"Zdravkovic","year":"2002","journal-title":"J Intern Med"},{"key":"10.1016\/j.medcli.2017.07.026_bib0200","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000006849","article-title":"Apolipoprotein A1 gene polymorphisms and risk of early coronary disease","volume":"90","author":"Reguero","year":"1998","journal-title":"Cardiology"},{"issue":"5 Suppl","key":"10.1016\/j.medcli.2017.07.026_bib0205","doi-asserted-by":"crossref","first-page":"1275s","DOI":"10.1093\/ajcn\/72.5.1275s","article-title":"Influence of genetic polymorphisms on responsiveness to dietary fat and cholesterol","volume":"72","author":"Ye","year":"2000","journal-title":"Am J Clin Nutr."},{"key":"10.1016\/j.medcli.2017.07.026_bib0210","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2017.07.026_bib0215","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(01)07098-2","article-title":"High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): A prospective study","volume":"358","author":"Walldius","year":"2001","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2017.07.026_bib0220","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01643.x","article-title":"The apoB\/apoA-I ratio: A strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy \u2013 A review of the evidence","volume":"259","author":"Walldius","year":"2006","journal-title":"J Intern Med."},{"key":"10.1016\/j.medcli.2017.07.026_bib0225","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1590\/S0066-782X2007000600014","article-title":"Apo B\/apo A-I ratio and cardiovascular risk prediction","volume":"88","author":"Lima","year":"2007","journal-title":"Arq Bras Cardiol."},{"key":"10.1016\/j.medcli.2017.07.026_bib0230","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1161\/CIR.0000000000000133","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: Executive summary. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2017.07.026_bib0235","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0735-1097(00)00804-4","article-title":"Myocardial infarction redefined\u2014A consensus document of The Joint European Society of Cardiology\/American College of Cardiology Committee for the redefinition of myocardial infarction","volume":"36","author":"Antman","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.medcli.2017.07.026_bib0240","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1001\/jama.291.18.2204","article-title":"Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: A prospective study of parents and offspring","volume":"291","author":"Lloyd-Jones","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2017.07.026_bib0245","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1309\/AJCPKPTXQ3QN1IFG","article-title":"Apolipoprotein A1 gene polymorphism (G-75A and C+83T) in patients with myocardial infarction: A pilot study in a north Indian population","volume":"134","author":"Dawar","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.medcli.2017.07.026_bib0250","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1203\/00006450-200104000-00013","article-title":"Variations in the promoter region of the apolipoprotein A-1 gene influence plasma lipoprotein(a) levels in Asian Indian neonates from Singapore","volume":"49","author":"Heng","year":"2001","journal-title":"Pediatr Res."},{"key":"10.1016\/j.medcli.2017.07.026_bib0255","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10238-009-0051-3","article-title":"Apolipoprotein A1 gene polymorphisms as risk factors for hypertension and obesity","volume":"9","author":"Chen","year":"2009","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.medcli.2017.07.026_bib0260","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.cca.2014.01.017","article-title":"Gender-specific associations of the APOA1 \u221275G>A polymorphism with several metabolic syndrome components in Turkish adults","volume":"431","author":"Coban","year":"2014","journal-title":"Clin Chim Acta."},{"key":"10.1016\/j.medcli.2017.07.026_bib0265","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gkr917","article-title":"HaploReg: A resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants","volume":"40","author":"Ward","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.medcli.2017.07.026_bib0270","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1101\/gr.139105.112","article-title":"Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors","volume":"22","author":"Wang","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.medcli.2017.07.026_bib0275","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1089\/gtmb.2015.0126","article-title":"Association between apolipoprotein B XbaI polymorphism and coronary heart disease in Han Chinese population: A meta-analysis","volume":"20","author":"Chen","year":"2016","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/j.medcli.2017.07.026_bib0280","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cca.2012.11.028","article-title":"Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvaestatina response","volume":"417","author":"Rodrigues","year":"2013","journal-title":"Clin Chim Acta."},{"key":"10.1016\/j.medcli.2017.07.026_bib0285","first-page":"260","article-title":"Association of the apolipoprotein B gene polymorphisms with essential hypertension in Northern Chinese Han population","volume":"20","author":"Zhao","year":"2007","journal-title":"Biomed Environ Sci."},{"key":"10.1016\/j.medcli.2017.07.026_bib0290","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1399-0004.1988.tb02892.x","article-title":"Further evidence for an association between the Xbal polymorphism at the apolipoprotein B locus and lipoprotein level","volume":"34","author":"Leren","year":"1988","journal-title":"Clin Genet."},{"key":"10.1016\/j.medcli.2017.07.026_bib0295","unstructured":"Wieland H. The clinical relevance of apolipoprotein determination. En: Rosseneu M, Widhalm K, Jarausch J, editores. Apolipoproteins in lipid disorders [Internet]. Viena: Springer; 1991 [consultado 25 Abr 2015]. p. 63-8. Disponible en: http:\/\/link.springer.com\/chapter\/10.1007\/978-3-7091-9148-4_6."},{"key":"10.1016\/j.medcli.2017.07.026_bib0300","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0022-2275(20)38087-1","article-title":"Human apolipoprotein A-I and A-II metabolism","volume":"23","author":"Schaefer","year":"1982","journal-title":"J Lipid Res."},{"key":"10.1016\/j.medcli.2017.07.026_bib0305","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/07435800009066166","article-title":"Effect of estrogen-progestin replacement therapy on plasma lipids and lipoproteins in postmenopausal women","volume":"26","author":"Rodriguez-Alem\u00e1n","year":"2000","journal-title":"Endocr Res."},{"key":"10.1016\/j.medcli.2017.07.026_bib0310","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-2004-835378","article-title":"Mechanistic insights and clinical relevance of the interaction between acute coronary syndromes and lipid metabolism","volume":"4","author":"Correia","year":"2004","journal-title":"Semin Vasc Med."},{"key":"10.1016\/j.medcli.2017.07.026_bib0315","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0140-6736(14)61217-4","article-title":"HDL and cardiovascular disease","volume":"384","author":"Rader","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2017.07.026_bib0320","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ncpcardio1040","article-title":"Is it time to discard the apo B:apo A-I ratio as a predictor of cardiovascular disease?","volume":"5","author":"Sierra-Johnson","year":"2008","journal-title":"Nat Rev Cardiol."},{"key":"10.1016\/j.medcli.2017.07.026_bib0325","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/qjmed\/hcl027","article-title":"Apolipoproteins as markers and managers of coronary risk","volume":"99","author":"Chan","year":"2006","journal-title":"QJM."},{"key":"10.1016\/j.medcli.2017.07.026_bib0330","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.medcli.2017.07.026_bib0335","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.106.633552","article-title":"Risk factors for acute myocardial infarction in Latin America: The INTERHEART Latin American study","volume":"115","author":"Lanas","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2017.07.026_bib0340","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2796.2005.01610.x","article-title":"Stroke mortality and the apoB\/apoA-I ratio: Results of the AMORIS prospective study","volume":"259","author":"Walldius","year":"2006","journal-title":"J Intern Med."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317306541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317306541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T12:33:42Z","timestamp":1659616422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775317306541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0025775317306541"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2017.07.026","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polimorfismos de los genes APOA1 y APOB y concentraciones de sus apolipoprote\u00ednas como biomarcadores de riesgo en el s\u00edndrome coronario agudo: relaci\u00f3n con la efectividad del tratamiento hipolipemiante","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2017.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}